COVID-19 (Coronavirus)

Information about changes at hospitals and health centres can be found at

Clinical drug trials

Official information request details

The number of clinical drug trials your DHB hosted in the 2017/2018 financial year + ongoing trials in 2019. Could figures please be broken-down by:

  1. The number of sponsored clinical trials involving devices and pharmaceuticals. 
  2. Phase 1 first-man-in clinical trials and phase 2a/b safety and efficacy trials, phase 3 broader efficacy trials and phase 4 post-marketing surveillance. And whether these trials are investigator-initiated or industry-sponsored commercially contracted trials.
  3. Investigator-initiated studies of non-therapeutic interventions, e.g. new diagnostics or new applications of existing diagnostics.
  4. Investigator-initiated observational studies including epidemiologic studies.
  5. Can you please also provide the aggregate income figure your DHB obtained from trials conducted in the 2017/2018 financial year.



Download (pdf, 300KB)

Back to Document Library

Page last updated: 26 June 2019

Is this page useful?